title: Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study.
abstract: BACKGROUND
  Dexmedetomidine, an alpha₂-adrenoceptor agonist, has been evaluated as an adjunct to anesthesia and for the delivery of sedation and perioperative hemodynamic stability. It provokes dose-dependent and centrally-mediated sympatholysis. Coronary artery bypass grafting (CABG) with extracorporeal circulation is a stressful procedure increasing sympathetic nervous system activity which could attenuate renal function due the interrelation of sympathetic nervous system, hemodynamics and renal function. We tested the hypothesis that dexmetomidine would improve kidney function in patients undergoing elective CABG during the first two postoperative days.
  
  
  METHODS
  This was a double-blind, randomized, parallel-group study. Patients with normal renal function and scheduled for elective CABG were randomized to placebo or to infusion of dexmedetomidine to achieve a pseudo steady-state plasma concentration of 0.60 ng/ml. The infusion was started after anesthesia induction and continued until 4 h after surgery. The primary endpoint was creatinine clearance. Other variables included urinary creatinine and output, fractional sodium and potassium excretion, urinary potassium, sodium and glucose, serum and urinary osmolality and plasma catecholamine concentrations. The data were analyzed with repeated-measures ANOVA or Cochran-Mantel-Haenszel test.
  
  
  RESULTS
  Sixty-six of 87 randomized patients were evaluable for analysis. No significant between-group differences were recorded for any indices of renal function except for a mean 74% increase in urinary output with dexmedetomidine in the first 4 h after insertion of a urinary catheter (p < 0.001). Confidence interval examination revealed that the sample size was large enough for the no-difference statement for creatinine clearance.
  
  
  CONCLUSIONS
  Use of intravenous dexmedetomidine did not alter renal function in this cohort of relatively low-risk elective CABG patients but was associated with an increase in urinary output.This study was carried out in 1994-1997 and was thus not registered.
authors: Department of Anaesthesiology, Intensive Care, Emergency Care and Pain Medicine, Turku University Hospital, Turku, Finland. kari.leino@tyks.fi
authors: Kari
authors: K
authors: Leino
authors: Markku
authors: M
authors: Hynynen
authors: Jouko
authors: J
authors: Jalonen
authors: Markku
authors: M
authors: Salmenperä
authors: Harry
authors: H
authors: Scheinin
authors: Riku
authors: R
authors: Aantaa
references: Anesth Analg. 1997 Nov;85(5):1136-42
references: 9356115
references: Anesthesiology. 1997 May;86(5):1055-60
references: 9158354
references: Anesthesiology. 1997 Feb;86(2):331-45
references: 9054252
references: Br J Clin Pharmacol. 1987 Nov;24(5):645-53
references: 2829953
references: J Thorac Cardiovasc Surg. 2005 Sep;130(3):746-52
references: 16153923
references: Anesth Analg. 2008 Jan;106(1):79-83, table of contents
references: 18165557
references: Eur J Anaesthesiol. 2006 Jan;23(1):17-22
references: 16390560
references: Asian Cardiovasc Thorac Ann. 2005 Dec;13(4):325-9
references: 16304219
references: J Clin Anesth. 2006 Sep;18(6):422-6
references: 16980158
references: Br J Anaesth. 2005 Jul;95(1):20-32
references: 15531622
references: Eur J Anaesthesiol. 2006 May;23(5):361-72
references: 16507202
references: J Intensive Care Med. 2008 Jan-Feb;23(1):3-18
references: 18230632
references: J Pharmacol Exp Ther. 1987 Mar;240(3):723-8
references: 2882013
references: Crit Care Med. 1996 Jun;24(6):947-52
references: 8681596
references: Anesthesiology. 2000 Aug;93(2):382-94
references: 10910487
references: Eur J Cardiothorac Surg. 2005 May;27(5):906-9
references: 15848334
references: Anaesthesia. 1997 Aug;52(8):736-44
references: 9291757
references: J Cardiothorac Vasc Anesth. 2003 Oct;17(5):576-84
references: 14579210
references: J Clin Invest. 1951 Feb;30(2):206-9
references: 14814213
references: J Cardiothorac Vasc Anesth. 2004 Aug;18(4):442-5
references: 15365924
references: J Pharmacol Exp Ther. 1997 Apr;281(1):62-9
references: 9103481
references: Crit Care. 2004 Aug;8(4):R204-12
references: 15312219
references: Intensive Care Med. 2003 Feb;29(2):201-7
references: 12594584
references: J Hypertens Suppl. 1988 Dec;6(2):S21-4
references: 2906696
references: J Am Soc Nephrol. 2005 Jan;16(1):195-200
references: 15563558